GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » EV-to-EBITDA
中文

Merit Medical Systems (Merit Medical Systems) EV-to-EBITDA

: 19.92 (As of Today)
View and export this data going back to 1992. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Merit Medical Systems's enterprise value is $4,559 Mil. Merit Medical Systems's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $229 Mil. Therefore, Merit Medical Systems's EV-to-EBITDA for today is 19.92.

The historical rank and industry rank for Merit Medical Systems's EV-to-EBITDA or its related term are showing as below:

MMSI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.42   Med: 21.34   Max: 43.29
Current: 19.92

During the past 13 years, the highest EV-to-EBITDA of Merit Medical Systems was 43.29. The lowest was 10.42. And the median was 21.34.

MMSI's EV-to-EBITDA is ranked worse than
65.44% of 489 companies
in the Medical Devices & Instruments industry
Industry Median: 14.89 vs MMSI: 19.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), Merit Medical Systems's stock price is $74.20. Merit Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.630. Therefore, Merit Medical Systems's PE Ratio for today is 45.52.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Merit Medical Systems EV-to-EBITDA Historical Data

The historical data trend for Merit Medical Systems's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.47 33.46 24.34 23.50 20.53

Merit Medical Systems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.50 23.02 25.49 19.33 20.53

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's EV-to-EBITDA falls into.



Merit Medical Systems EV-to-EBITDA Calculation

Merit Medical Systems's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4558.713/228.892
=19.92

Merit Medical Systems's current Enterprise Value is $4,559 Mil.
Merit Medical Systems's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $229 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems  (NAS:MMSI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Merit Medical Systems's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=74.20/1.630
=45.52

Merit Medical Systems's share price for today is $74.20.
Merit Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.630.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Merit Medical Systems EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems (Merit Medical Systems) Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. Majority of the revenue is earned from Cardiovascular segment. United States generates majority of the revenue.
Executives
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos director, officer: President & CEO
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102